We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cadence Design Systems
CDNS
$95.2B
| $30M | 0.08% |
281,200
+4,900
| +2% | +$516K |
|
277
Cummins
CMI
$88.2B
| $29.7M | 0.07% |
+140,667
| New | +$28M |
|
|
SCHW
278
Charles Schwab
SCHW
$186B
| $29.6M | 0.07% |
817,625
-29,000
| -3% | -$1.01M |
|
|
NGA.U
279
DELISTED
Northern Genesis Acquisition Corp. Units, each consisting of one share of common stock and one-half
NGA.U
| $29.5M | 0.07% |
+2,950,000
| New | +$29.4M |
|
280
Cintas
CTAS
$81.3B
| $29.4M | 0.07% |
353,600
-37,600
| -10% | -$2.9M |
|
281
Clorox
CLX
$12.9B
| $29.3M | 0.07% |
139,614
-5,239
| -4% | -$1.17M |
|
|
PE
282
DELISTED
PARSLEY ENERGY INC
PE
| $29.3M | 0.07% |
3,128,587
-1,205,000
| -28% | -$12.9M |
|
|
BHVN
283
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $29.3M | 0.07% |
450,000
+250,000
| +125% | +$16.4M |
|
|
HOLX
284
DELISTED
Hologic
HOLX
| $29.2M | 0.07% |
439,976
-259,400
| -37% | -$16.4M |
|
285
HP
HPQ
$26.5B
| $29.1M | 0.07% |
1,531,936
-19,900
| -1% | -$363K |
|
286
Archer Daniels Midland
ADM
$37B
| $29M | 0.07% |
623,692
-5,800
| -0.9% | -$254K |
|
287
American Water Works
AWK
$26.9B
| $29M | 0.07% |
199,999
-6,500
| -3% | -$921K |
|
288
Rockwell Automation
ROK
$49.4B
| $28.8M | 0.07% |
130,585
+63,390
| +94% | +$14.2M |
|
289
Consolidated Edison
ED
$39.6B
| $28.7M | 0.07% |
+368,792
| New | +$27.2M |
|
290
EOG Resources
EOG
$70.7B
| $28.7M | 0.07% |
797,800
+498,900
| +167% | +$22.4M |
|
291
OGE Energy
OGE
$9.69B
| $28.6M | 0.07% |
+952,840
| New | +$30M |
|
292
Best Buy
BBY
$17.2B
| $28.4M | 0.07% |
255,200
-8,300
| -3% | -$849K |
|
293
Travere Therapeutics
TVTX
$5.88B
| $28.3M | 0.07% |
1,534,500
-100,000
| -6% | -$1.94M |
|
294
Marvell Technology
MRVL
$192B
| $28M | 0.07% |
704,861
-565,600
| -45% | -$20.8M |
|
295
D.R. Horton
DHI
$41.9B
| $28M | 0.07% |
369,600
-8,100
| -2% | -$553K |
|
|
ABMD
296
DELISTED
Abiomed Inc
ABMD
| $27.8M | 0.07% |
100,313
-76,700
| -43% | -$22.1M |
|
297
Marriott International
MAR
$93.2B
| $27.6M | 0.07% |
298,525
-9,600
| -3% | -$906K |
|
298
Analog Devices
ADI
$190B
| $27.6M | 0.07% |
236,457
-419,900
| -64% | -$49.2M |
|
299
Xenon Pharmaceuticals
XENE
$6.14B
| $27.1M | 0.07% |
2,450,000
+425,000
| +21% | +$5M |
|
300
TransDigm Group
TDG
$69B
| $27.1M | 0.07% |
56,975
+4,027
| +8% | +$1.89M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.